Table 1.
Characteristic | Prescription | ||
---|---|---|---|
Number in millions | Percent | Per 1,000 persons | |
Antibiotic category | |||
Penicillins | 17.07 | 69.6 | 53.9 |
Lincosamides | 3.57 | 14.6 | 11.3 |
Macrolides | 1.33 | 5.4 | 4.2 |
Cephalosporins | 1.24 | 5.1 | 3.9 |
β –lactams, increased activity | 0.56 | 2.3 | 1.8 |
Tetracycline | 0.47 | 1.9 | 1.5 |
Quinolones | 0.21 | 0.8 | 0.6 |
Trimethoprim/Sulfamethoxazole | 0.05 | 0.2 | 0.2 |
Urinary anti-infectives | 0.02 | 0.1 | 0.1 |
Other | 0.00 | 0.0 | 0.0 |
Total | 24.52 | 100.0 | 77.5 |
Antibiotic agent | |||
Amoxicillin | 13.80 | 56.3 | 43.6 |
Clindamycin | 3.57 | 14.4 | 11.3 |
Penicillin V | 3.24 | 13.2 | 10.2 |
Cephalexin | 1.19 | 4.9 | 3.8 |
Azithromycin | 1.14 | 4.7 | 3.6 |
Amoxicillin clavulanate | 0.56 | 2.3 | 1.8 |
Doxycycline | 0.45 | 1.7 | 1.4 |
Ciprofloxacin | 0.16 | 0.6 | 0.5 |
Erythromycin | 0.15 | 0.4 | 0.5 |
Sulfamethoxazole/trimethoprim | 0.05 | 0.2 | 0.2 |
Others | 0.21 | 1.3 | 0.6 |
Sex of patient | |||
Male | 10.73 | 43.9 | 68.9 |
Female | 13.70 | 56.1 | 85.2 |
Age group of patient (years) | |||
0-2 | 0.03 | 0.1 | 2.8 |
3-9 | 0.75 | 3.1 | 26.1 |
10-19 | 1.11 | 4.6 | 26.5 |
20-39 | 5.76 | 23.9 | 67.4 |
40-64 | 10.79 | 44.8 | 103.6 |
65+ | 5.63 | 23.4 | 126.0 |
Region of prescriber | |||
Northeast | 4.87 | 19.9 | 87.0 |
Midwest | 5.43 | 22.1 | 80.3 |
South | 8.96 | 36.6 | 75.6 |
West | 5.26 | 21.4 | 70.7 |